StockStory Favors AMETEK and Novanta, Flags Genco’s Cash Flow
The publisher pointed to AMETEK’s margins and Novanta’s growth outlook, while citing weaker cash-flow trends at Genco.
Makkler Newsroom · Oct 6, 01:23 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $30.35 (+23.3%)
Prices may be delayed and are for informational purposes only - not investment advice.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.